SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Stablecoin Development Corp. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in West Palm Beach, FL.

Stablecoin Development Corp.

SDEVs speculative surge, tied to its SKY-token treasury exposure and traders low-float short-squeeze thesis, has reversed sharply amid trading halts. Bears point to a short-seller report and dilution risk, while bulls dispute the report and continue to argue that scarce shares could fuel another squeeze.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulfs AI/HPC data-center pivot and expanded contracted power capacity at its Muskie campus are driving attention, alongside bullish analyst coverage. The shares continued decline has split traders: bulls point to AI power demand and the companys pipeline, while bears cite weak price action, management concerns, and higher financing costs across the sector.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas sizable order for electronic safe-and-arm devices, tied to its GATE and Bron acquisitions, and a bullish Citizens analyst initiation are driving attention. Bulls see the developments as validation of the defense business and potential pressure on heavily shorted shares, while skeptics argue that contract news has not overcome dilution concerns and persistent selling.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

A high-volume breakout has drawn attention, with traders linking optimism to Michael Caputos appointment to the Presidents Cancer Panel and speculation that it could broaden access to ImmunityBios Anktiva; no access change is confirmed. The community is also debating whether the move reflects short covering or squeeze potential versus momentum buying, while some traders caution that it has come without a fresh company announcement.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors positive 24-month HOPE-3 open-label extension data for deramiocel in Duchenne muscular dystrophy is driving attention, with traders focused on whether the results strengthen the amended FDA application for an upper-limb indication ahead of the November decision. Optimism about the data and possible approval is tempered by concerns that open-label evidence may not resolve the FDAs earlier efficacy questions, alongside frustration over muted, volatile trading and speculation about short selling.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

MARA is drawing attention for volatile weakness and apparent decoupling from Bitcoin, with traders frustrated that the shares often sell off even when BTC is firm and some attributing the action to short pressure or manipulation. Bullish traders see Bitcoin strength and high short interest as potential fuel for a squeeze, while skeptics point to the lack of confirmed AI/HPC tenant updates and criticize management.

Chipotle Mexican Grill, Inc. engages in the business of developing and operating restaurants that serve a relevant menu of burritos, burrito bowls, quesadillas, tacos, and salads made using fresh, high-quality ingredients. The company was founded by Steve Ells in 1993 and is headquartered in Newport Beach, CA.

Chipotle Mexican Grill

Unconfirmed takeover speculationincluding traders claims of a possible private-equity offerhas become a major topic, though some question the rumor and say a deal may be unlikely. The discussion also centers on CMGs sharp decline and weakness in restaurant stocks, with traders asking why it is falling even as delivery-related peers rise.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is drawing attention after a cluster of bullish analyst upgrades, led by Melius Researchs shift to Buy on expectations that Azure growth and enterprise demand for secure AI tools can benefit the company. Traders are leaning bullish on a breakout, while skeptics warn that repeated resistance and past selloffs after upgrades could limit follow-through.

Vistra Corp. is a holding company, which engages in the provision of electricity and power generation. It operates through the following segments: Retail, Texas, East, West, and Asset Closure. The Retail segment includes sale of electricity and natural gas to residential, commercial, and industrial customers. The Texas and East segments are involved in electricity generation, wholesale energy sales and purchases, commodity risk management activities, fuel production and fuel logistics management. The West segment represents the company's electricity generation operations in CAISO. The Asset Closure segment refers to the decommissioning and reclamation of retired plants and mines. The company was founded in 1882 and is headquartered in Irving, TX.

Vistra Corp

Reports of a planned federal loan to fund upgrades at Vistras nuclear plants are driving attention, with traders linking the added capacity to rising AI and data-center power demand. Many see the financing as bullish, while others are frustrated that volatile trading and selling have muted the stocks response; the loan remains a reported plan.

Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. The company was founded by Grant E. Pickering and Jeff Fairman on November 27, 2013, and is headquartered in San Carlos, CA.

Vaxcyte Inc

Vaxcyte shares surged after its VAX-31 pneumococcal vaccine met all primary endpoints in the pivotal Phase 3 OPUS-1 trial, including favorable immune-response comparisons with existing vaccines. Traders are split between celebrating the clinical result and warning that the sharp rally could fade, with some positioning short or taking profits.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Robbins LLP Urges ARDX Stockholders Who Lost Money Investing in Ardelyx, Inc. to Contact the Firm for Information About Leading the Class Action

Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of persons and entities who purchased or otherwise acquired Ardelyx, Inc. (NASDAQ: ARDX) common stock between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"). Ardelyx, Inc. develops...

ARDX Deadline Alert: SueWallSt Reminds Ardelyx, Inc. (ARDX) Investors of Securities Class Action Deadline on November 16, 2026

ARDX Deadline Alert: SueWallSt Reminds Ardelyx, Inc. (ARDX) Investors of Securities Class Action Deadline on November 16, 2026 ARDX Deadline Alert: SueWallSt Reminds Ardelyx, Inc. (ARDX) Investors of Securities Class Action Deadline on November 16, 2026PR NewswireNEW YORK, Oct. 1, 2026A securities...

ARDX UPCOMING DEADLINE: Levi & Korsinsky Alerts Ardelyx, Inc. Stockholders of Securities Class Action - Contact the Firm

ARDX UPCOMING DEADLINE: Levi & Korsinsky Alerts Ardelyx, Inc. Stockholders of Securities Class Action - Contact the Firm ARDX UPCOMING DEADLINE: Levi & Korsinsky Alerts Ardelyx, Inc. Stockholders of Securities Class Action - Contact the FirmPR NewswireNEW YORK, Sept. 30, 2026Time-Sensitive...

ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit

ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud LawsuitPR NewswireNEW YORK, Sept. 28, 2026 NEW YORK, Sept. 28, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces...

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ardelyx, Inc. of Class Action Lawsuit and Upcoming Deadlines - ARDX

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ardelyx, Inc. of Class Action Lawsuit and Upcoming Deadlines - ARDX INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ardelyx, Inc. of Class Action Lawsuit and Upcoming...

SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of November 16, 2026 in Ardelyx, Inc. Lawsuit - ARDX

SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of November 16, 2026 in Ardelyx, Inc. Lawsuit - ARDX SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of November 16, 2026 in Ardelyx, Inc. Lawsuit - ARDXPR NewswireNEW YORK, Sept. 24, 2026 Ardelyx's Chief Commercial Officer...

Levi & Korsinsky Reminds Ardelyx, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 16, 2026 - ARDX

Levi & Korsinsky Reminds Ardelyx, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 16, 2026 - ARDX Levi & Korsinsky Reminds Ardelyx, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 16, 2026 - ARDXPR...

Bronstein, Gewirtz & Grossman LLC Urges Ardelyx, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC Urges Ardelyx, Inc. Investors to Act: Class Action Filed Alleging Investor Harm Bronstein, Gewirtz & Grossman LLC Urges Ardelyx, Inc. Investors to Act: Class Action Filed Alleging Investor HarmPR NewswireNEW YORK, Sept. 22, 2026NEW YORK, Sept. 22, 2026 /PRNewswire...

Rosen Law Firm Urges Ardelyx, Inc. (NASDAQ: ARDX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the Class Period). Ardelyx develops and commercializes medicines.For more information...

ARDX Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Ardelyx, Inc.

ARDX Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Ardelyx, Inc. ARDX Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Ardelyx, Inc.PR NewswireSAN DIEGO, Sept. 21...

Ardelyx, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Its products include IBSRELA and XPHOZAH. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

ARDX Stock Tumbles As Xphozah Loses Final Medicare Reimbursement Battle  

Equity

Bearish Sentiment

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be this week?

Current Price	$3.32
Prev Close	$3.34
Open	$3.35
Dividend Yield	0.00%
50-Day Moving Average	$3.95
Beta	0.97
Avg. Volume	4.16M
PE Ratio	-14.77

52-Week High	$8.40
52-Week Low	$3.29
Market Capitalization	$832.29M
EPS (Annual)	-$0.2556
Price to Book	5.58
Revenue Per Employee	$832,965.23

Feed

News

Sentiment

Earnings

Fundamentals

Info

ARDX Fundamentals